Schroder Investment Management Group
ECYT

Schroder Investment Management Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Schroder Investment Management Group’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,873
Closed -$175K – 1336
2018
Q3 		$175K Buy
+9,873
New +$170K ﹤0.01% 1146

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Schroder Investment Management Group's ECYT Position: Q4 2018 in Review

Schroder Investment Management Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 9,873 shares — an estimated $175K sold.

Schroder Investment Management Group first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $175K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Schroder Investment Management Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Schroder Investment Management Group sold 9,873 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $175K.
  • Schroder Investment Management Group first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Schroder Investment Management Group's Endocyte, Inc. Common Stock position peaked at $175K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Schroder Investment Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.